New drug - Intelence
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
However, unfortunately this will take time so I do believe we need to take a pragmatic approach.
Most patients who receive end- of-life care have a GP or medical consultant involved in their care. Therefore, I'm sure it is possible to have a patient-specific plan, or a clinical management plan under supplementary prescribing. This would ensure the patient continues to receive the medications they need.
Rather than being alarmist, we should look at how we can remedy the situation, remaining inside the law.
We, at the ANP, will continue to lobby for the necessary arrangements to be made to enable nurses to prescribe for their patients exactly what they need. We will advise members on our progress.
Barbara Stuttle CBE, director of quality and nursing, Essex, and chair, Association for Nurse Prescribing.
Comment below and tell us what you think
Quick search - use * for an abbreviated search, eg nico*
Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more
Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more
Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more
Comments
Only registered users may comment. Log in now or register for a free account.